Contemporary Management of Patients with Systemic Lupus Erythematosus: A Case-based Approac

Access Activity

Overview / Abstract:

This modular continuing education activity provides an update on the epidemiology, monitoring, and treatment of patients with systemic lupus erythematosus (SLE). Diane Kamen, MD, and Anca Askanase, MD, examine the current research on demographic groups with an increased risk of SLE and its severe complications, including lupus nephritis (LN). They also review the application of the most current treatment goals and classification criteria to speed diagnosis and guide disease activity monitoring. The expert faculty provide guidance on the integration of newly approved treatments into the EULAR treatment algorithms for SLE, and how these treatments can be used for patients with LN. Two case studies are utilized to illustrate the application of key concepts.


Jul 27, 2024


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME



Credits / Hours




Is This Activity Certified for "Live" Credit?


Presenters / Authors / Faculty

nca D. Askanase, MD, MPH
Professor of Medicine
Director, Lupus Center
Director, Rheumatology Clinical Trials
Columbia University Medical Center
New York, New York

Diane L. Kamen, MD
Professor of Medicine
Division of Rheumatology and Immunology
Medical University of South Carolina
Charleston, South Carolina

Sponsors / Supporters / Grant Providers

This educational activity is supported by an educational grant from GSK.

Keywords / Search Terms

Annenberg Center for Health Sciences at Eisenhower systemic lupus erythematosus Free CE CME Live CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map